Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The action of trental was studied in 125 patients with initial manifestations of cerebral circulation insufficiency (CCI) secondary to vasomotor
dystonia
or atherosclerosis.
Trental
was used in the form of tablets (100 mg 3 times daily) for 60 days. To assess the therapeutic effect of trental, the authors analyzed the time-course of subjective manifestations, parameters of echopulsography of cerebral vessels and biomicroscopy of the conjunctiva, and the data of the total blood count and the rheological properties of the blood. In patients with initial manifestations of CCI trental decreased the cerebral vascular resistance and improved the venous outflow, reduced platelet adhesive and aggregation properties and diminished blood viscosity. It also elevated the spontaneous fibrinolytic activity of the blood. The advisability of selective administration of the drug for treating initial manifestations of CCI was confirmed.
...
PMID:[Indications for using trental in the initial manifestations of inadequate blood supply to the brain]. 395 93
Microcirculatory and rheologic disorders associated with neurocirculatory
dystonia
, essential hypertension and coronary disease are reported. The pathogenetic role of microcirculatory and rheologic disorders in cardiovascular diseases is outlined. The value of erythrocyte deformability for rheologic disorders is established. The efficiency of
Trental
treatment for coronary disease is demonstrated.
...
PMID:[Microcirculation and rheology of cardiovascular diseases: physiological, clinical and pharmacological aspects]. 665 91